BETHESDA, Md.--(BUSINESS WIRE)--Jan. 3, 2005--RegeneRx Biopharmaceuticals, Inc. (OTCBB:RGRX) (www.regenerx.com) announced today that it closed on the first tranche of a $5.86 million private placement of its common stock. Participants in the transaction include current RegeneRx investors as well as a number of new institutional investors. The transaction is being led by Sigma-Tau Group, headquartered in Rome and RegeneRx's largest stockholder. The first $1.25 million closed on December 31, 2004 and the remaining $4.61 million, for which definitive agreements have already been executed, is scheduled to close the first week of January 2005. ThinkEquity Partners LLC acted as sole placement agent for the transaction.
